Akari Therapeutics (AKTX)

Akari Therapeutics (AKTX) Financial Statements


Akari Therapeutics Financial Overview

Akari Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.346; its P/E ratio is -0.47; Akari Therapeutics is scheduled to report earnings on September 27, 2023, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue-$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT-$ -5.82M$ -5.24M$ -5.87M$ -1.46M
EBITDA-$ -5.82M$ -5.24M$ -5.87M$ -1.46M
Net Income Common Stockholders-$ -5.68M$ -5.18M$ -5.79M$ -1.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.20M$ 8.15M$ 16.72M$ 9.36M$ 13.39M
Total Assets$ 13.83M$ 11.37M$ 19.45M$ 11.65M$ 14.72M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -13.20M$ -8.15M$ -16.72M$ -9.36M$ -13.39M
Total Liabilities$ 12.04M$ 3.05M$ 5.52M$ 6.09M$ 3.36M
Stockholders Equity$ 1.79M$ 8.33M$ 13.93M$ 5.55M$ 11.36M
Cash Flow-
Free Cash Flow-$ -8.57M$ -5.05M$ -5.00M$ -1.56M
Operating Cash Flow-$ -8.57M$ -5.05M$ -5.00M$ -1.56M
Investing Cash Flow-----
Financing Cash Flow-$ 0.00$ 12.37M$ 1.12M$ 11.18M
Currency in USD

Akari Therapeutics Earnings and Revenue History

Akari Therapeutics Debt to Assets

Akari Therapeutics Cash Flow

Akari Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis